Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Massi

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|September 10, 2014
CDKN2A mutations could influence the dermoscopic pattern of presentation of multiple primary melanoma: a clinical dermoscopic genetic studyV De Giorgi, I Savarese, A D'Errico, et al.
Le Mali Medical|July 28, 2018
[Clinical and etiological aspects of focal epilepsy in children at Yaoundé Gynaeco-obstetric Hospital (Cameroon)]S Nguefack, D Massi Gams, B Moifo, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 11, 2011
Risk of second primary melanoma: how should be long follow-up be? Ratio of observed and expected casesV de Giorgi, S Rossari, F Papi, et al.
Journal of Dermatological Science|December 17, 2008
Tacrolimus causes reduced GLI1 expression and phenotypic changes in the TE 354.T basal cell carcinoma cell lineP Di Gennaro, R Sestini, S Bacci, et al.
The Journal of Pathology|June 29, 2007
Analysis of protease-activated receptor-1 and -2 in human scar formationS Materazzi, S Pellerito, C Di Serio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 4, 2015
The status of PD-L1 and tumor-infiltrating immune cells predict resistance and poor prognosis in BRAFi-treated melanoma patients harboring mutant BRAFV600D Massi, D Brusa, B Merelli, et al.
Oral Diseases|June 20, 2007
Expression of protease-activated receptor-1 and -2 in orofacial granulomatosisS Ketabchi, D Massi, G Ficarra, et al.
Environmental Pollution (Barking, Essex : 1987)|July 21, 2020
What is in our seas? Assessing anthropogenic litter on the seafloor of the central Mediterranean SeaG Garofalo, F Quattrocchi, G Bono, et al.
ESMO Open|April 14, 2022
Acral lentiginous melanoma histotype predicts outcome in clinical stage I-II melanoma patients: an International multicenter studyM Mandalà, P Rutkowski, F Galli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 17, 2014
PD-L1 marks a subset of melanomas with a shorter overall survival and distinct genetic and morphological characteristicsD Massi, D Brusa, B Merelli, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
Journal of the European Academy of Dermatology and Venereology : JEADV|September 10, 2014
CDKN2A mutations could influence the dermoscopic pattern of presentation of multiple primary melanoma: a clinical dermoscopic genetic studyV De Giorgi, I Savarese, A D'Errico, et al.
Le Mali Medical|July 28, 2018
[Clinical and etiological aspects of focal epilepsy in children at Yaoundé Gynaeco-obstetric Hospital (Cameroon)]S Nguefack, D Massi Gams, B Moifo, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 11, 2011
Risk of second primary melanoma: how should be long follow-up be? Ratio of observed and expected casesV de Giorgi, S Rossari, F Papi, et al.
Journal of Dermatological Science|December 17, 2008
Tacrolimus causes reduced GLI1 expression and phenotypic changes in the TE 354.T basal cell carcinoma cell lineP Di Gennaro, R Sestini, S Bacci, et al.
The Journal of Pathology|June 29, 2007
Analysis of protease-activated receptor-1 and -2 in human scar formationS Materazzi, S Pellerito, C Di Serio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 4, 2015
The status of PD-L1 and tumor-infiltrating immune cells predict resistance and poor prognosis in BRAFi-treated melanoma patients harboring mutant BRAFV600D Massi, D Brusa, B Merelli, et al.
Oral Diseases|June 20, 2007
Expression of protease-activated receptor-1 and -2 in orofacial granulomatosisS Ketabchi, D Massi, G Ficarra, et al.
Environmental Pollution (Barking, Essex : 1987)|July 21, 2020
What is in our seas? Assessing anthropogenic litter on the seafloor of the central Mediterranean SeaG Garofalo, F Quattrocchi, G Bono, et al.
ESMO Open|April 14, 2022
Acral lentiginous melanoma histotype predicts outcome in clinical stage I-II melanoma patients: an International multicenter studyM Mandalà, P Rutkowski, F Galli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 17, 2014
PD-L1 marks a subset of melanomas with a shorter overall survival and distinct genetic and morphological characteristicsD Massi, D Brusa, B Merelli, et al.
Pageof 11